How should we use transdermal fentanyl (TF) for pain management in palliative care patients?

被引:5
作者
Fainsinger, RL [1 ]
Bruera, E [1 ]
机构
[1] EDMONTON GEN HOSP,PALLAT CARE PROGRAM,EDMONTON,AB,CANADA
关键词
D O I
10.1177/082585979601200110
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:48 / 53
页数:6
相关论文
共 30 条
[1]  
AHMEDZAI S, 1994, J DRUG DEV, V6, P93
[2]   DAY-TO-DAY TITRATION OF TRANSDERMAL FENTANYL IS UNWISE [J].
BROOKS, D .
SUPPORTIVE CARE IN CANCER, 1995, 3 (03) :210-210
[3]   USE OF THE EDMONTON INJECTOR FOR PARENTERAL OPIOID MANAGEMENT OF CANCER PAIN - A STUDY OF 100 CONSECUTIVE PATIENTS [J].
BRUERA, E ;
VELASCOLEIVA, A ;
SPACHYNSKI, K ;
FAINSINGER, R ;
MILLER, MJ ;
MACEACHERN, T .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1993, 8 (08) :525-528
[4]  
CALIS KA, 1992, CLIN PHARMACY, V11, P22
[5]  
ESTEVE M, 1991, ANESTHESIOLOGY, V75, pA705
[6]  
Fainsinger R, 1994, J Palliat Care, V10, P55
[7]  
FAINSINGER RL, 1994, 10TH INT C CAR TERM
[8]  
FAINSINGER RL, IN PRESS J PAIN S MA
[9]   THE TRANSDERMAL ADMINISTRATION OF FENTANYL IN THE TREATMENT OF POSTOPERATIVE PAIN - PHARMACOKINETICS AND PHARMACODYNAMIC EFFECTS [J].
GOURLAY, GK ;
KOWALSKI, SR ;
PLUMMER, JL ;
CHERRY, DA ;
GAUKROGER, P ;
COUSINS, MJ .
PAIN, 1989, 37 (02) :193-202
[10]   TRANSDERMAL FENTANYL IN CANCER PAIN - CONVERSION FROM ORAL MORPHINE [J].
HANKS, GW ;
FALLON, MT .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) :87-87